Search results
Results from the WOW.Com Content Network
"Using stem cells from patients with heart failure caused by chemo, we are actively developing new drugs and cell-based treatments that we believe will transform the lives of patients with these ...
Fetal tissue implant or fetal cell therapy is an experimental medical therapy where researchers implant tissue from a fetus into a person as treatment of a disease. In the case of Parkinson's disease , it is hoped that the fetal tissue would produce chemicals, specifically dopamine , which is lacking in the diseased brain.
Embryonic stem cells divide more rapidly than adult stem cells, potentially making it easier to generate large numbers of cells for therapeutic means. In contrast, adult stem cell might not divide fast enough to offer immediate treatment. [36] Embryonic stem cells have greater plasticity, potentially allowing them to treat a wider range of ...
Different types of mesenchymal stem cells and other additives are still being researched to find the best type of cell and method for long-term treatment. [23] Adipose-derived mesenchymal cells are currently the most often used for stem cell treatment of osteoarthritis because of the non-invasive harvesting. This is a recently developed, non ...
In December, Pope Francis said taking vaccines derived from aborted cells could be "morally acceptable." Bishops urge Catholics to avoid the Johnson & Johnson vaccine if possible because it was ...
The majority of stem cells present in the amniotic fluid share many characteristics, which suggests they may have a common origin. [1]In 2007, it was confirmed that the amniotic fluid contains a heterogeneous mixture of multipotent cells after it was demonstrated that they were able to differentiate into cells from all three germ layers but they could not form teratomas following implantation ...
A savior sibling may be the solution for any disease treated by hematopoietic stem cell transplantation.It is effective against genetically detectable (mostly monogenic) diseases, e.g. Fanconi anemia, [4] Diamond–Blackfan anemia [5] and β-thalassemia, in the ailing sibling, since the savior sibling can be selected to not have inherited the disease.
However, about three years after treatment, two of the children developed T-cell leukemia due to insertion of the IL2RG gene near the LMO2 gene and thereby activating the LMO2 gene (a known oncogene). [42] A third child developed leukemia within two years of that study being published, likely as a direct result of the therapy. [43]